184 related articles for article (PubMed ID: 38355394)
1. Hypothesis of a CD137/Eomes activating axis for effector T cells in HPV oropharyngeal cancers.
Baudouin R; Tartour E; Badoual C; Hans S
Mol Med; 2024 Feb; 30(1):26. PubMed ID: 38355394
[TBL] [Abstract][Full Text] [Related]
2. CD137 Agonist Therapy Can Reprogram Regulatory T Cells into Cytotoxic CD4+ T Cells with Antitumor Activity.
Akhmetzyanova I; Zelinskyy G; Littwitz-Salomon E; Malyshkina A; Dietze KK; Streeck H; Brandau S; Dittmer U
J Immunol; 2016 Jan; 196(1):484-92. PubMed ID: 26608920
[TBL] [Abstract][Full Text] [Related]
3. The immune microenvironment of HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma: a multiparametric quantitative and spatial analysis unveils a rationale to target treatment-naïve tumors with immune checkpoint inhibitors.
Tosi A; Parisatto B; Menegaldo A; Spinato G; Guido M; Del Mistro A; Bussani R; Zanconati F; Tofanelli M; Tirelli G; Boscolo-Rizzo P; Rosato A
J Exp Clin Cancer Res; 2022 Sep; 41(1):279. PubMed ID: 36123711
[TBL] [Abstract][Full Text] [Related]
4. Tbet-positive regulatory T cells accumulate in oropharyngeal cancers with ongoing tumor-specific type 1 T cell responses.
Santegoets SJ; Duurland CL; Jordanova ES; van Ham JJ; Ehsan I; van Egmond SL; Welters MJP; van der Burg SH
J Immunother Cancer; 2019 Jan; 7(1):14. PubMed ID: 30658697
[TBL] [Abstract][Full Text] [Related]
5. An Immunotherapeutic CD137 Agonist Releases Eomesodermin from ThPOK Repression in CD4 T Cells.
Mittal P; Abblett R; Ryan JM; Hagymasi AT; Agyekum-Yamoah A; Svedova J; Reiner SL; St Rose MC; Hanley MP; Vella AT; Adler AJ
J Immunol; 2018 Feb; 200(4):1513-1526. PubMed ID: 29305435
[TBL] [Abstract][Full Text] [Related]
6. Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.
Oguejiofor K; Hall J; Slater C; Betts G; Hall G; Slevin N; Dovedi S; Stern PL; West CM
Br J Cancer; 2015 Sep; 113(6):886-93. PubMed ID: 26313665
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of FOXP3+ regulatory T cells for patients with locally advanced oropharyngeal squamous cell carcinoma.
Hur JY; Ku BM; Park S; Jung HA; Lee SH; Ahn MJ
PLoS One; 2022; 17(10):e0274830. PubMed ID: 36201479
[TBL] [Abstract][Full Text] [Related]
8. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
[TBL] [Abstract][Full Text] [Related]
9. Infiltrating lymphocytes and human papillomavirus-16--associated oropharyngeal cancer.
Wansom D; Light E; Thomas D; Worden F; Prince M; Urba S; Chepeha D; Kumar B; Cordell K; Eisbruch A; Taylor J; Moyer J; Bradford C; D'Silva N; Carey T; McHugh J; Wolf G;
Laryngoscope; 2012 Jan; 122(1):121-7. PubMed ID: 22183632
[TBL] [Abstract][Full Text] [Related]
10. A beneficial tumor microenvironment in oropharyngeal squamous cell carcinoma is characterized by a high T cell and low IL-17(+) cell frequency.
Punt S; Dronkers EA; Welters MJ; Goedemans R; Koljenović S; Bloemena E; Snijders PJ; Gorter A; van der Burg SH; Baatenburg de Jong RJ; Jordanova ES
Cancer Immunol Immunother; 2016 Apr; 65(4):393-403. PubMed ID: 26899388
[TBL] [Abstract][Full Text] [Related]
11. Eomesodermin Expression in CD4+ T Cells Restricts Peripheral Foxp3 Induction.
Lupar E; Brack M; Garnier L; Laffont S; Rauch KS; Schachtrup K; Arnold SJ; Guéry JC; Izcue A
J Immunol; 2015 Nov; 195(10):4742-52. PubMed ID: 26453746
[TBL] [Abstract][Full Text] [Related]
12. Exploring the link between human papilloma virus and oral and oropharyngeal cancers.
Khode SR; Dwivedi RC; Rhys-Evans P; Kazi R
J Cancer Res Ther; 2014; 10(3):492-8. PubMed ID: 25313727
[TBL] [Abstract][Full Text] [Related]
13. Oropharyngeal squamous cell carcinomas differentially express granzyme inhibitors.
van Kempen PM; Noorlag R; Swartz JE; Bovenschen N; Braunius WW; Vermeulen JF; Van Cann EM; Grolman W; Willems SM
Cancer Immunol Immunother; 2016 May; 65(5):575-85. PubMed ID: 26993499
[TBL] [Abstract][Full Text] [Related]
14. Tumor-infiltrating FoxP3+ T cells are associated with poor prognosis in oral squamous cell carcinoma.
Hayashi T; Yoshikawa K; Suzuki S; Gosho M; Ueda R; Kazaoka Y
Clin Exp Dent Res; 2022 Feb; 8(1):152-159. PubMed ID: 34319010
[TBL] [Abstract][Full Text] [Related]
15. ICOS
Nagase H; Takeoka T; Urakawa S; Morimoto-Okazawa A; Kawashima A; Iwahori K; Takiguchi S; Nishikawa H; Sato E; Sakaguchi S; Mori M; Doki Y; Wada H
Int J Cancer; 2017 Feb; 140(3):686-695. PubMed ID: 27756099
[TBL] [Abstract][Full Text] [Related]
16. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
17. Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.
Lechien JR; Seminerio I; Descamps G; Mat Q; Mouawad F; Hans S; Julieron M; Dequanter D; Vanderhaegen T; Journe F; Saussez S
Cells; 2019 Sep; 8(9):. PubMed ID: 31510065
[TBL] [Abstract][Full Text] [Related]
18. Composition and plasticity of triple-negative breast carcinoma-infiltrating regulatory T cells.
Cai B; Ma P; Ding P; Sun DW; Bu Q; Zhang J
APMIS; 2020 Mar; 128(3):260-269. PubMed ID: 31811667
[TBL] [Abstract][Full Text] [Related]
19. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
20. Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.
Bartkowiak T; Singh S; Yang G; Galvan G; Haria D; Ai M; Allison JP; Sastry KJ; Curran MA
Proc Natl Acad Sci U S A; 2015 Sep; 112(38):E5290-9. PubMed ID: 26351680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
